The nuclear receptor (NR) superfamily of transcription factors regulates various key aspects of physiological processes; however, their role(s) in immune cells' function are just beginning to unravel. Although few NRs have been shown to be critical for dendritic cell (DC) function, a lack of knowledge about their complete representation in DCs has limited the ability to harness their full potential. Here, we performed a comprehensive NR expression profiling and identified the key members of NR superfamily being expressed in immature, immunogenic, and tolerogenic DCs. Comparative analysis revealed discrete changes in the expression of various NRs among the studied DC subtypes, indicating a likely role in the modulation of DC functionality. Next, we characterized Nr4a2, a member of orphan NR family, and found that it suppresses the activation of bone marrow derived dendritic cells triggered by LPS. Overexpression and knockdown of Nr4a2 demonstrated that Nr4a2 orchestrates the expression of immunoregulatory genes, hence inducing a tolerogenic phenotype in bone marrow derived dendritic cells. Furthermore, we also found that Nr4a2 provides protection from EAE by promoting an increase in Treg cells, while limiting effector T cells. Our findings suggest a previously unidentified role for Nr4a2 as a regulator of DC tolerogenicity and demonstrate its potential as therapeutic target in DC-associated pathophysiologies.
Keywords: Dendritic cells EAE Immune tolerance Nr4a2 Nuclear receptors Treg cellsAdditional supporting information may be found in the online version of this article at the publisher's web-site
IntroductionDendritic cells (DCs) are indispensable immune sentinels that bridge the innate and adaptive immune responses. They have been primarily looked upon as inducers of immunity-immunogenic DCs; however, there is a growing body of evidence to support another facet of their function in induction and maintenance of tolerance-tolerogenic DCs. The phenotypic characteristics distinguishing these two functional DC phenotypes, immunogenic or tolerogenic, have begun to unravel. [1,9]. Interestingly, many of these modulators are known to be able to exert their effects through the members of nuclear receptor (NR) superfamily, which comprises 49 members in mice and 48 in humans.The NR superfamily comprises ligand-sensitive transcription factors that regulate various metabolic, developmental, homeostatic, and other physiological processes by modulating the expression of target genes [10,11]. NRs have been classified into three categories depending upon the nature of their ligands: (i) endocrine NRs that mediate the effects of endocrine hormones, (ii) orphan NRs whose regulatory ligands have not yet been identified, and (iii) adopted orphan NRs that were originally identified as orphan NRs, but were subsequently found to bind dietary lipids as their ligands [12,13]. Unlike other transcription factors, NRs are exceptionally promising therapeutic targets in biomedicine, because of their druggable potential. Consequently, NRs ...